| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-13 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-13 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-12 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-12 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |